BJG-05-039   Click here for help

GtoPdb Ligand ID: 12266

Compound class: Synthetic organic
Comment: BJG-05-039 is a PROTAC that is designed to degrade PAK1 protein [1]. It fuses the PAK1-selective (allosteric) inhibitor NVS-PAK1-1 [2], with the cereblon-binder lenalidomide. Inhibition of PAK1 reduces the growth and survival of PAK1-overexpressing malignancies in vivo [2]. Targeted degradation is expected to produce the same effect.
Click here for help
2D Structure
Click here for help
Click here for structure editor
Physico-chemical Properties
Click here for help
Hydrogen bond acceptors 13
Hydrogen bond donors 4
Rotatable bonds 17
Topological polar surface area 155.55
Molecular weight 820.31
XLogP 6.64
No. Lipinski's rules broken 3
SMILES / InChI / InChIKey
Click here for help
Canonical SMILES FC(CN1c2ccc(cc2C(=Nc2c1ccc(c2)F)N[C@@H]1CCN(C1)C(=O)NCCCCCCCCNc1cccc2c1C(=O)N(C2=O)C1CCC(=O)NC1=O)Cl)F
Isomeric SMILES O=C1CCC(N2C(=O)c3cccc(NCCCCCCCCNC(=O)N4CC[C@@H](NC5=Nc6cc(F)ccc6N(CC(F)F)c6ccc(Cl)cc56)C4)c3C2=O)C(=O)N1
InChI InChI=1S/C41H44ClF3N8O5/c42-24-10-12-31-28(20-24)37(49-30-21-25(43)11-13-32(30)52(31)23-34(44)45)48-26-16-19-51(22-26)41(58)47-18-6-4-2-1-3-5-17-46-29-9-7-8-27-36(29)40(57)53(39(27)56)33-14-15-35(54)50-38(33)55/h7-13,20-21,26,33-34,46H,1-6,14-19,22-23H2,(H,47,58)(H,48,49)(H,50,54,55)/t26-,33?/m1/s1
InChI Key UZPKWEBZEBROEX-UOQVMRJOSA-N
References
1. Chow HY, Karchugina S, Groendyke BJ, Toenjes S, Hatcher J, Donovan KA, Fischer ES, Abalakov G, Faezov B, Dunbrack R et al.. (2022)
Development and Utility of a PAK1-Selective Degrader.
J Med Chem, 65 (23): 15627-15641. [PMID:36416208]
2. Hawley E, Gehlhausen J, Karchugina S, Chow HY, Araiza-Olivera D, Radu M, Smith A, Burks C, Jiang L, Li X et al.. (2021)
PAK1 inhibition reduces tumor size and extends the lifespan of mice in a genetically engineered mouse model of Neurofibromatosis Type 2 (NF2).
Hum Mol Genet, 30 (17): 1607-1617. [PMID:34075397]